This clinical trial is focused on studying the treatment of first-degree perineal tears, which are small tears that can occur in the area between the vagina and anus during childbirth. The study will compare two different methods of pain relief used during the repair of these tears. One method involves using a cream called EMLA, which contains two active substances, lidocaine and prilocaine. This cream is applied directly to the skin. The other method uses an injection of lidocaine hydrochloride, which is a solution injected into the area to numb it.

The purpose of the study is to compare how effective these two methods are in managing pain during the repair of the tear and in the two hours following childbirth. Participants in the study will receive either the cream or the injection, and their pain levels will be monitored and recorded. The study aims to provide insights into which method offers better pain relief for women experiencing first-degree perineal tears.

Throughout the study, participants will be observed to assess their pain levels and the characteristics of the tear, as well as other factors related to childbirth and the postpartum period. This includes monitoring the onset of labor, any alternative pain management therapies used, and the practice of skin-to-skin contact with the newborn. The study will also consider the characteristics of the newborn, such as weight and sex, and the mother’s age and number of previous births. The trial is expected to run until May 2025.